Signaturefd, LLC Pmv Pharmaceuticals, Inc. Transaction History

Signaturefd, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	BUY	$4.77 - $9.16 $658 - $1,264	138 Added 45.7%	440 $2,000
Q4 2022 Jan 27, 2023	BUY	$8.17 - $12.95 $1,830 - $2,900	224 Added 287.18%	302 $2,000
Q3 2022 Nov 08, 2022	SELL	$11.4 - $17.18 $957 - $1,443	-84 Reduced 51.85%	78 $1,000
Q2 2022 Aug 10, 2022	BUY	$9.23 - $22.43 $175 - $426	19 Added 13.29%	162 $2,000
Q1 2022 May 02, 2022	BUY	$14.86 - $23.55 $2,124 - $3,367	143 New	143 $3,000
Q4 2021 Jan 25, 2022	SELL	$19.99 - $30.24 $579 - $876	-29 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$26.84 - $36.58 $778 - $1,060	29 New	29 $1,000

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.